These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 16875761

  • 1. Treatment with infliximab: Implications in oral surgery? A case report.
    Ciantar M, Adlam DM.
    Br J Oral Maxillofac Surg; 2007 Sep; 45(6):507-10. PubMed ID: 16875761
    [Abstract] [Full Text] [Related]

  • 2. Sézary syndrome in a patient receiving infliximab for ankylosing spondylitis.
    Dauendorffer JN, Rivet J, Allard A, Bachelez H.
    Br J Dermatol; 2007 Apr; 156(4):742-3. PubMed ID: 17263820
    [Abstract] [Full Text] [Related]

  • 3. A series of complications after third molar osteotomy in a pancytopenia patient and spontaneous healing after bone marrow transplantation.
    Klatt JC, Gröbe A, Schmelzle R, Atac A, Heiland M, Blessmann M, Pohlenz P.
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2508-12. PubMed ID: 21571420
    [No Abstract] [Full Text] [Related]

  • 4. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY, Browning JC, Larsen F, Hsu S.
    Dermatol Online J; 2008 Sep 15; 14(9):12. PubMed ID: 19061594
    [Abstract] [Full Text] [Related]

  • 5. Osteomyelitis of odontogenic origin: report of case and review.
    Beurle JG, Goode M, Higa L.
    J Can Dent Assoc (Tor); 1970 Sep 15; 36(9):338-41. PubMed ID: 5272037
    [No Abstract] [Full Text] [Related]

  • 6. Third molar complications requiring hospitalization.
    Kunkel M, Morbach T, Kleis W, Wagner W.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep 15; 102(3):300-6. PubMed ID: 16920537
    [Abstract] [Full Text] [Related]

  • 7. Cryptococcal meningitis in a patient treated with infliximab.
    Muñoz P, Giannella M, Valerio M, Soria T, Díaz F, Longo JL, Bouza E.
    Diagn Microbiol Infect Dis; 2007 Apr 15; 57(4):443-6. PubMed ID: 17240111
    [Abstract] [Full Text] [Related]

  • 8. Extraction of impacted mandibular third molars: postoperative complications and their risk factors.
    Blondeau F, Daniel NG.
    J Can Dent Assoc; 2007 May 15; 73(4):325. PubMed ID: 17484797
    [Abstract] [Full Text] [Related]

  • 9. Do pathologies associated with impacted lower third molars justify prophylactic removal? A critical review of the literature.
    Adeyemo WL.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct 15; 102(4):448-52. PubMed ID: 16997110
    [Abstract] [Full Text] [Related]

  • 10. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.
    Danko JR, Gilliland WR, Miller RS, Decker CF.
    Scand J Infect Dis; 2009 Oct 15; 41(4):252-5. PubMed ID: 19266397
    [Abstract] [Full Text] [Related]

  • 11. Toxicity of infliximab in the course of treatment of Crohn's disease.
    Bratcher JM, Korelitz BI.
    Expert Opin Drug Saf; 2006 Jan 15; 5(1):9-16. PubMed ID: 16370952
    [Abstract] [Full Text] [Related]

  • 12. Third molar surgery: current concepts and controversies. Part 1.
    Sands T, Pynn BR, Nenniger S.
    Oral Health; 1993 May 15; 83(5):11-4, 17. PubMed ID: 8233412
    [Abstract] [Full Text] [Related]

  • 13. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS.
    Rheumatology (Oxford); 2009 Nov 15; 48(11):1451-4. PubMed ID: 19748965
    [Abstract] [Full Text] [Related]

  • 14. Diffuse large B-cell lymphoma in a patient with rheumatoid arthritis treated with infliximab and methotrexate.
    Nakashima C, Tanioka M, Takahashi K, Miyachi Y.
    Clin Exp Dermatol; 2008 Jul 15; 33(4):437-9. PubMed ID: 18485021
    [Abstract] [Full Text] [Related]

  • 15. [Development of tuberculosis after treatment with the TNF-alpha inhibitor infliximab].
    Dahl M, Ravn P.
    Ugeskr Laeger; 2005 Jan 31; 167(5):527-8. PubMed ID: 15745179
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
    Braun J, Baraliakos X, Listing J, Fritz C, Alten R, Burmester G, Krause A, Schewe S, Schneider M, Sörensen H, Zeidler H, Sieper J.
    Ann Rheum Dis; 2008 Mar 31; 67(3):340-5. PubMed ID: 17967831
    [Abstract] [Full Text] [Related]

  • 18. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?
    Roux CH, Brocq O, Leccia N, Giacchero D, Breuil V, Albert C, Lacour J, Perrin C, Euller-Ziegler L.
    J Rheumatol; 2007 Feb 31; 34(2):434-7. PubMed ID: 17295430
    [Abstract] [Full Text] [Related]

  • 19. Complications of third molar surgery.
    Bouloux GF, Steed MB, Perciaccante VJ.
    Oral Maxillofac Surg Clin North Am; 2007 Feb 31; 19(1):117-28, vii. PubMed ID: 18088870
    [Abstract] [Full Text] [Related]

  • 20. Atypical cutaneous tuberculosis in a patient with rheumatoid arthritis treated with infliximab.
    Asano Y, Kano Y, Shiohara T.
    Acta Derm Venereol; 2008 Feb 31; 88(2):183-4. PubMed ID: 18311458
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.